https://www.thebodypro.com/category/hiv-treatments-in-development/tag/conference-coverage

The Latest

clinical trial

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.
injectable

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...

David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

CROI 2021 Takeaway: Long-Acting Antiretrovirals for HIV Treatment

David Alain Wohl, M.D., talks through new data regarding long-acting antiretroviral therapy for HIV—and touches on the uncertainties clinicians face in incorporating this new treatment method into their practice.

By David Alain Wohl, M.D.
injection vials

Long-Acting HIV Treatment and PrEP Pipeline Update: So Many Formulations!

CROI 2021 featured new research on a host of long-acting antiretrovirals in development, including less-frequent treatment injections, a weekly pill for HIV treatment, injectable PrEP, vaginal PrEP rings, and PrEP implants.

By Larry Buhl
injection

Long-Acting Injectable HIV Treatment Still Appears Safe and Effective—and Largely Accessible Despite COVID-19 Disruptions

Research newly presented at the IDWeek 2020 conference yields further promising data on injectable cabotegravir/rilpivirine, as well as encouraging info regarding COVID-19 disruptions in treatment delivery.

By Larry Buhl
Ricardo Diaz

Researcher Behind "Brazil Patient," the Latest HIV Remission Case, Explains How It Happened

The international news story that broke at AIDS 2020, explained by the lead researcher.

By Terri Wilder, M.S.W.
injectable

The Monthly Injectable HIV Drug Works Just as Well When Given Every Two Months

Although injectable cabotegravir/rilpivirine is still yet to be approved by the FDA, evidence keeps mounting on the effectiveness of the shot for HIV treatment.

By Sony Salzman
stem cell transplant device

Durable HIV Remission in London Patient, the Second Person Cured of HIV

Researchers are happy but cautious, because this isn’t a strategy for most people with HIV.

By Sony Salzman
Several Medication Pill Bottles On Table In Front Of Windows

Patients With HIV Should Think About How Many Pills They Take a Day

Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.

By Mathew Rodriguez